Dr. Clinton David Protack, MD

Dr. Protack practices at Vascular Surgery Associates in Bel Air, Maryland.

Dr. Protack's NPI, 1952563801, was assigned on July 1, 2008. Dr. Protack graduated from University of Rochester School of Medicine and Dentistry in 2008. Dr. Protack holds Maryland license D87273.

Dr. Protack's primary practice is Vascular Surgery Associates, at 520 Upper Chesapeake Dr, Bel Air, MD 21014 in Harford County. The practice phone is (410) 879-2006.

Dr. Protack's primary practice is Vascular Surgery Associates in Bel Air, Maryland. Dr. Protack is also affiliated with University of Maryland Upper Chesapeake Medical Center Bel Air. The medical group on file is Vascular Surgery Associates, LLC. Dmand AI also links Dr. Protack to 3 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Protack practices, 5 sites in all. Vendor and product names are available with a free account.

Vascular surgery is Dr. Protack's primary specialty in the NPI Registry, under taxonomy code 2086S0129X. Dr. Protack is licensed in Maryland.

CMS data shows 3,072 Medicare services from Dr. Protack across 31 procedure codes in 2024, for 1,770 Medicare patients. Medicare paid $353,767 for them.

CMS counts 1,770 Medicare patients who saw Dr. Protack in 2024. The largest group is 75 to 84, with 707 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 13% are also on Medicaid. Their average risk score is 2.09, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Protack's median patient age at 73, with 50% women.

In 2024, Dr. Protack wrote 290 Medicare Part D claims for 131 patients. 83% of them were for generic drugs. CMS names the drug for 268 of them, across 4 drugs with 11 or more claims each, at $48,818 in total drug cost. In 2023, CMS named 148 claims across 4 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 86 out of 100 for Dr. Protack for performance year 2024, reported as part of a group. Dr. Protack accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 36 procedures of leg revascularization (restoring blood flow) by Dr. Protack, more than 91% of the clinicians it reports for that procedure.

Dmand AI links 25 papers to Dr. Protack, published from 2011 to 2024. 2012 was the busiest year, with 5. The most frequent topics are Arteriovenous Shunt, Surgical, Mice, Inbred C57BL and Veins. Dr. Protack has published most often in J Vasc Surg. Dr. Protack's most frequent co-authors are Alan Dardik, MD, PhD, Roland Assi, MD and Caroline Jadlowiec, MD.

CMS Open Payments shows 40 general payments to Dr. Protack from 18 drug and device companies from 2017 to 2025. Food and beverage make up the largest share, 70% of the total. Medtronic Vascular, Inc. paid the most, $963.

Dr. Protack graduated from University of Rochester School of Medicine and Dentistry in 2008.